Skip to content

Clinical trials

Substance-Related Disorders trials in Switzerland with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Substance-Related Disorders Phase: Not applicable Country / region: Switzerland Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20143
20172
20181
20201
20221
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting4
Not yet recruiting2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Hospital, Basel, Switzerland3
Louise Penzenstadler2
NORCE Norwegian Research Centre AS1
Prof. Dagmar M. Haller1
Prof. Dr. med. Egemen Savaskan1
Silke Wiegand-Grefe, Prof. Dr.1
Susanne Walitza1
University of Basel1
University of Bern1
University of Geneva, Switzerland1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Substance-Related Disorders13
Mood Disorders2
Alcoholism1
Amphetamine-Related Disorders1
Binge Drinking1
Mental Disorders1
Neurotic Disorders1
Personality Disorders1
Schizophrenia Spectrum and Other Psychotic Disorders1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.